# Orakl Oncology raises $34M to expand cancer drug prediction platform

_Published Thursday, November 12, 2026 at 12:41 PM EST · Capital, AI · Latest · Tier 2 — Notable_

![Orakl Oncology raises $34M to expand cancer drug prediction platform — Primary](https://media.thenextweb.com/2026/10/ai-chip-brain-inside-light-bulb-purple-background.jpg)

Paris-based Orakl Oncology has raised a $34M Series A co-led by Norrsken VC and Singular, bringing total funding to $50M. The company grows small copies of patients' tumours, tests drugs on them and combines the results with medical records to train AI that predicts clinical trial outcomes.

The financing will support five times more laboratory data, expansion into lung and gastric cancers, and teams in the US and UK. An April preprint tested the model retrospectively on 23 colorectal and pancreatic cancer trials, mostly involving standard chemotherapy; performance on newer drugs still needs to be proven.

## Sources

- [The Next Web](https://thenextweb.com/news/orakl-oncology-34m-series-a-ai-cancer-drug-prediction)

---
Canonical: https://techandbusiness.org/newswire/95z4nQt1qXBpsbo3RcgJMf
Published: 2026-11-12T17:41:09.184Z
Story chronology: 2026-11-12T17:31:47.000Z
Retrieved: 2026-11-12T19:44:43.356Z
Publisher: Tech & Business (techandbusiness.org)